A Study of Patients With AIDS Syndrome
Trial Summary
What is the purpose of this trial?
The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.
Research Team
William G. Powderly
Principal Investigator
Charles S. Rabkin
Principal Investigator
Ann C. Collier
Principal Investigator
Univ of Washington
David A. Wohl
Principal Investigator
Univ of North Carolina
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- N/A (N/A)
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
Dr. Jeanne Marrazzo
National Institute of Allergy and Infectious Diseases (NIAID)
Chief Executive Officer since 2023
MD, MPH
Dr. H. Clifford Lane
National Institute of Allergy and Infectious Diseases (NIAID)
Chief Medical Officer
MD
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School